Cargando…
Adjuvants are Key Factors for the Development of Future Vaccines: Lessons from the Finlay Adjuvant Platform
The development of effective vaccines against neglected diseases, especially those associated with poverty and social deprivation, is urgently needed. Modern vaccine technologies and a better understanding of the immune response have provided scientists with the tools for rational and safer design o...
Autores principales: | Pérez, Oliver, Romeu, Belkis, Cabrera, Osmir, González, Elizabeth, Batista-Duharte, Alexander, Labrada, Alexis, Pérez, Rocmira, Reyes, Laura M., Ramírez, Wendy, Sifontes, Sergio, Fernández, Nelson, Lastre, Miriam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3845353/ https://www.ncbi.nlm.nih.gov/pubmed/24348475 http://dx.doi.org/10.3389/fimmu.2013.00407 |
Ejemplares similares
-
Pilot scale production of the vaccine adjuvant Proteoliposome derived Cochleates (AFCo1) from Neisseria meningitidis serogroup B
por: Zayas, Caridad, et al.
Publicado: (2013) -
106 Neisseria Meningitidis Derived Proteoliposome as an Adjuvant for Allergen Vaccines
por: González, Wendy Ramírez, et al.
Publicado: (2012) -
Immunogenicity of a novel anti-allergic vaccine based on house dust mite purified allergens and a combination adjuvant in a murine prophylactic model
por: Ramírez, Wendy, et al.
Publicado: (2022) -
Human prophylactic vaccine adjuvants and their determinant role in new vaccine formulations
por: Pérez, O., et al.
Publicado: (2012) -
Evaluating the immunogenicity of an intranasal vaccine against nicotine in mice using the Adjuvant Finlay Proteoliposome (AFPL1)
por: Fraleigh, Nya L., et al.
Publicado: (2016)